In-Hospital LSVT BIG Training Versus Structured Rehabilitation Treatment in Parkinson’s Disease: Feasibility and Primary Evaluation on Functional and Respiratory Outcomes
Source abstract
Abstract
Lee Silverman Voice Treatment (LSVT) BIG, primarily developed for outpatient use, is a prominent intervention for patients with Parkinson’s disease thanks to its high-intensity, repetitive exercises involving large movements. This study first evaluated the feasibility of an in-hospital LSVT BIG training program by assessing recruitment capability, compliance, and adherence. The secondary objective was to evaluate the effects of LSVT BIG training on gait, balance, and functional outcomes, as well as respiratory function and quality of life, in comparison with a progressive structured rehabilitation program (SC) of similar intensity and frequency. In-hospital LSVT BIG training for people with Parkinson’s disease was feasible, with 95% recruitment rates and 100% safety and adherence. SC (n = 19) and LSVT BIG (n = 19) significantly improved (for all, p < 0.05) pre-to-post balance (MiniBESTest) and lower limb effort tolerance (6MWT). Delta changes between groups favored LSVT for upper limb effort tolerance (UULEX level, time, p < 0.001), gait speed, and UULEX SatO2 mean, PCEF, MiniBESTest and 6MWT (for all, p < 0.05). Evaluation of the probability associated with the LSVT BIG showed MiniBESTest as being 8.5 times more likely to exceed the MCID compared to SC. Quality of life was unchanged across both groups. This study successfully demonstrates the feasibility of in-hospital LSVT-BIG® training, and comparison of outcomes, although exploratory and underpowered, showed better improvements in mobility, balance, and effort tolerance, suggesting a complementary role within traditional rehabilitation protocols.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Cerebral Palsy and Movement Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
NeuroRehabilitation of the Institute of Castel Goffredo, Istituti Clinici Scientifici Maugeri IRCCS, 46042 Castel Goffredo, MN, Italy
Scientific Direction of the Institute of Lumezzane, Istituti Clinici Scientifici Maugeri IRCCS, 25065 Lumezzane, BS, Italy
Respiratory Rehabilitation of the Institute of Lumezzane, Istituti Clinici Scientifici Maugeri IRCCS, 25065 Lumezzane, BS, Italy
References (60)
Show source-provided references
1. Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology10.1016/j.cger.2019.08.002 ↗
2. Epidemiology of Parkinson’s disease10.1007/s00702-017-1686-y ↗
3. Depression and Anxiety in Parkinson Disease10.1016/j.cger.2019.09.012 ↗
4. The Universal Prescription for Parkinson’s Disease: Exercise
5. Evidence-based analysis of physical therapy in Parkinson’s disease with recommendations for practice and research10.1002/mds.21244 ↗
6. Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology10.1212/01.wnl.0000206363.57955.1b ↗
7. Physical exercise for people with Parkinson’s disease: A systematic review and network meta-analysis
8. Rehabilitation for Parkinson’s disease: Current outlook and future challenges10.1016/j.parkreldis.2015.09.005 ↗
9. Effects of external rhythmical cueing on gait in patients with Parkinson’s disease: A systematic review10.1191/0269215505cr906oa ↗
10. Cueing training in the home improves gait-related mobility in Parkinson’s disease: The RESCUE trial10.1136/jnnp.200X.097923 ↗
11. Training improves the speed of aimed movements in Parkinson’s disease10.1093/brain/121.3.505 ↗
12. Repetitive training of compensatory steps: A therapeutic approach for postural instability in Parkinson’s disease10.1136/jnnp.2003.016550 ↗
13. Nordic walking improves mobility in Parkinson’s disease10.1002/mds.22293 ↗
14. A randomised controlled trial of a home based exercise programme to reduce the risk of falling among people with Parkinson’s disease10.1136/jnnp.2006.099333 ↗
15. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson’s disease10.1002/mds.20997 ↗
16. Training BIG to move faster: The application of the speed-amplitude relation as a rehabilitation strategy for people with Parkinson’s disease10.1007/s00221-005-0179-7 ↗
17. Comparing exercise in Parkinson’s disease–The Berlin LSVTBIG® BIG study10.1002/mds.23212 ↗
18. Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson’s disease: A systematic review and meta-analysis10.1177/0269215517734385 ↗
19. Effects of Lee Silverman Voice Treatment BIG and conventional physiotherapy on non-motor and motor symptoms in Parkinson’s disease: A randomized controlled study comparing three exercise models10.1177/1756286420986744 ↗
20. LSVT® BIG versus progressive mobility training through synchronous telerehabilitation in Parkinson’s disease: A randomized controlled trial10.1007/s10072-024-07322-0 ↗
21. Validation study of the Hoehn And Yahr scale included in the MDS-UPDRS10.1002/mds.27242 ↗
22. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician10.1016/0022-3956(75)90026-6 ↗
23. Psychophysical bases of perceived exertion10.1249/00005768-198205000-00012 ↗
24. ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD. An official American Thoracic Society/European Respiratory Society statement: Update on limb muscle dysfunction in chronic obstructive pulmonary disease10.1164/rccm.201402-0373ST ↗
25. Validation of the Italian version of the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale10.1007/s10072-012-1112-z ↗
26. Refining the ten-meter walking test for use with neurologically impaired people10.1016/S0031-9406(05)61264-3 ↗
27. Validation of the freezing of gait questionnaire in patients with Parkinson’s disease10.1002/mds.21745 ↗
28. Using psychometric techniques to improve the Balance Evaluation Systems Test: The mini-BESTest10.2340/16501977-0537 ↗
29. The instrumented timed up and go test: Potential outcome measure for disease modifying therapies in Parkinson’s disease10.1136/jnnp.2009.173740 ↗
30. Measuring balance in the elderly: Preliminary development of an instrument10.3138/ptc.41.6.304 ↗
31. Reference values for the five-repetition sit-to-stand test: A descriptive meta-analysis of data from elders10.2466/pms.103.1.215-222 ↗
32. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories (2002). ATS statement: Guidelines for the 6-minute walk test. Am. J. Respir. Crit. Care Med., 166, 111–117.10.1164/ajrccm.166.1.at1102 ↗
33. Effect of muscle fatigue on internal model formation and retention during reaching with the arm10.1152/japplphysiol.00140.2005 ↗
34. Reference equations for the six-minute walk in healthy adults10.1164/ajrccm.158.5.9710086 ↗
35. (1983). Standardized lung function testing. Report working party. Bull. Eur. Physiopathol. Respir., 19, 1–95.
36. Accuracy of portable devices in measuring peak cough flow10.1088/0967-3334/36/2/243 ↗
37. The Parkinson fatigue scale10.1016/j.parkreldis.2004.07.007 ↗
38. The Parkinson’s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson’s disease summary index score10.1093/ageing/26.5.353 ↗
39. Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson’s Disease Utilizing LSVT BIG
40. Estimation of minimal clinically important difference for quadriceps and inspiratory muscle strength in older outpatients with chronic obstructive pulmonary disease: A prospective cohort study10.1298/ptr.E10049 ↗
41. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: A systematic review10.1111/jep.12629 ↗
42. Responsiveness and minimal clinically important difference of the Mini-BESTest in patients with Parkinson’s disease10.1016/j.gaitpost.2020.05.004 ↗
43. R Core Team (2025, July 27). R: A Language and Environment for Statistical Computing, Available online: http://www.R-project.org.
44. Effect Size Guidelines for Individual and Group Differences in Physiotherapy
45. Effects of LSVT-BIG via telerehabilitation on non-motor and motor symptoms and quality of life in Parkinson’s disease10.1007/s13760-022-02104-x ↗
46. Vitacca, M., Olivares, A., Comini, L., Vezzadini, G., Langella, A., Luisa, A., Petrolati, A., Frigo, G., and Paneroni, M. (2021). Exercise Intolerance and Oxygen Desaturation in Patients with Parkinson’s Disease: Triggers for Respiratory Rehabilitation?. Int. J. Environ. Res. Public Health, 18.10.3390/ijerph182312298 ↗
47. The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson’s disease: A randomized controlled trial10.1002/brb3.3458 ↗
48. Amplitude-oriented exercise in Parkinson’s disease: A randomized study comparing LSVT-BIG and a short training protocol10.1007/s00702-014-1245-8 ↗
49. Mehdizadeh, M., Fereshtehnejad, S.-M., Landers, M.R., Sharabiani, P.T.A., Shati, M., Mortazavi, S.S., Habibi, S.A.H., Mansoori, K., Meimandi, M., and Nodehi, Z. (2025). Responsiveness of the mini-balance evaluation systems test, dynamic gait index, Berg balance scale, and performance-oriented mobility assessment in parkinson’s disease. Sci. Rep., 15.10.1038/s41598-025-08463-8 ↗
50. LSVT BIG and long-term retention of functional gains in individuals with Parkinson’s disease10.1080/09593985.2020.1780655 ↗
51. Effect of Muscle Training on Dyspnea in Patients with Chronic Obstructive Pulmonary Disease: A Meta-Analysis of Randomized Controlled Trials10.1097/MD.0000000000024930 ↗
52. Resistance arm training in patients with COPD: A Randomized Controlled Trial10.1378/chest.10-1292 ↗
53. Respiratory Response and Ventilatory Muscle Recruitment During Arm Elevation in Normal Subjects10.1378/chest.101.2.336 ↗
54. Effectiveness of Expiratory Muscle Strength Training on Expiratory Strength, Pulmonary Function and Cough in the Adult Population: A Systematic Review10.1016/j.physio.2019.06.002 ↗
55. Effect of Expiratory Muscle Training on Peak Cough Flow in Children and Adolescents with Cystic Fibrosis: A Randomized Controlled Trial10.1002/ppul.25259 ↗
56. Defective motor control of coughing in Parkinson’s disease10.1164/ajrccm.158.2.9705094 ↗
57. The Effects of Respiratory Training in Parkinson’s Disease: A Systematic Review
58. The effects of respiratory muscle training on peak cough flow in patients with Parkinson’s disease: A randomized controlled study10.1177/0269215518774832 ↗
59. Effects of Expiratory Muscle Training and Air Stacking on Peak Cough Flow in Individuals with Parkinson’s Disease10.1007/s00408-019-00291-8 ↗
60. Motivation Matters: Elucidating Factors Driving Exercise in People with Parkinson’s Disease10.1093/ptj/pzaf048 ↗